ASBEST KULLANIMININ YAYGIN OLDUĞU BİR BÖLGEDE KADINLARDA MEZOTELYOMANIN KLİNİK VE DEMOGRAFİK ÖZELLİKLERİ

Öz

Malign Mezotelyoma (MM) etiyolojisinde genellikle çevresel ve mesleksel asbest maruziyeti rol alır. Ayrıca yine bir fibröz zeolit olan erionit de suçlanmaktadır. Ülkemizde çevresel asbest ve erionit teması nedeniyle MM yaygın bir kanser türüdür. Çalışmamızda 2005-2011 yılları arasında hastanemizde MM tanısı konan 77 kadın hasta retrospektif olarak değerlendirildi. MM hastalarının dosyaları ayrıntılı olarak incelendi. Çalışmaya alınan hastaların demografik verileri, yaş, şikayet, radyolojik bulgular, tanı yöntemleri, hastalık evreleri daha önceden hazırlanan standart formlara kaydedildi. MM hastalarının yaş ortalaması 57 ± 14.1 yıl idi. Elli yedi hastada (%74) olguda çevresel asbest maruziyeti mevcuttu ve ortalama temas süresi 30.6 yıldı. Hastalardan 21'i (%27.3) asbest kullanımının yaygın olduğu Ergani ilçesinden başvurmuştu. Toplam 63 hastada (%81.8) nefes darlığı, 44 hastada (%57.1) göğüs ağrısı ve 16 hastada (%20.8) kilo kaybı vardı. Ortalama semptom süresi 5.7 ± 4.6 aydı. Ayrıca 47 hastada (%61) histopatolojik tip olarak epitelyal tip olarak saptandı. Hastalarda ortalama sağ kalım 9.54 ± 6.9 ay olarak bulundu. Malign mezotelyoma çevresel asbest maruziyetinin fazla olduğu bölgelerde yaşayan kadınlarda uyumlu semptom ve bulguları olanlarda akla getirilmelidir. Bu kişilerde özellikle plevral tutuluma dikkat edilmelidir. Ülkemizde bu hastalığın önlenmesi için çevresel asbest kullanımının tamamen terk edilmesi için çalışmalar yapmak faydalı olabilecektir.

Anahtar Kelimeler

• Malign mezotelyoma, çevresel asbest, kadın

CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF WOMEN MESOTHELIOMA IN COMMON USE OF ASBESTOS IN THE REGION

Abstract

Malignant mesothelioma (MM) in the etiology of environmental and occupational exposure to asbestos often plays a role. In addition, it is a fibrous zeolite erionite the accused. MM due to environmental asbestos and erionite is a common theme in our country is a type of cancer. In our study, 77 female patients diagnosed with MM at our hospital between 2005-2011 were evaluated retrospectively. MM patients were examined in detail in the files. The demographic data of the patients, age, complaints, radiological findings, diagnostic methods, the standard forms prepared in advance stages of disease were recorded. The mean age of MM patients was 57 ± 14.1 years. Fifty-seven patients (74%) patients had environmental asbestos exposure and the average exposure time is 30.6 years. 21 patients (27.3%), the use of asbestos was commonly applied to the Ergani district. Total of 63 patients (81.8%) dyspnea, 44 patients (57.1%) chest pain and 16 patients (20.8%) had weight loss. The average duration of symptoms was 5.7 ± 4.6 months. In addition, 47 patients (61%) histological type was the epithelial type. The mean survival was found to be 9.54 ± 6.9 months. Malignant mesothelioma should be considered in patients who women living in areas with more than environmental exposure to asbestos, with compatible symptoms and signs. These people should be especially careful of pleural involvement. In our country, for the prevention of this disease to be completely abandoned the use of environmental asbestos studies will be useful to do.

Keywords

• Malignant mesothelioma, environmental asbestos, women

Kaynakça

1. 1. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Povince. Br J Indust Med 1960; 17: 266-71.
2. 2. Emri S, Akbulut H, Zorlu F, Dinçol D, Akay H, Güngen Y, Içli F. Prognostic significance of flow cytometric DNA analysis ›n patients with malignant pleural mesothelioma. Lung Cancer 2001 33(2-3): 109-14.
3. 3. Bar›fl B, Demir AU, Shehu V, Karakoca Y, K›sac›k G, Bar›fl YI. Environmental fibrous zeolite (erionite) exposure and malignant tumors other than mesothelioma. J Environ Pathol Toxicol Oncol 1996; 15: 183-9.
4. 4. Dumortier P, Coplü L, de Maertelaer V, Emri S, Baris I, De Vuyst P. Assessment of environmental asbestos exposure in Turkey by bronchoalveolar lavage. Am J Respir Crit Care Med 1998; 158: 1815-24.
5. 5. Selcuk ZT, Coplu L, Emri S, Kalyoncu AF, Sahin AA, Baris YI. Malignant pleural mesothelioma due to environmental mineral fiber exposure in Turkey. Analysis of 135 cases. Chest 1992; 102: 790-6.
6. 6. Dawson A, Gibbs AR, Pooley FD, Griffiths DM, Hoy J. Malignant mesothelioma in women. Thorax 1993; 48: 269-74.
7. 7. Metintas M, Ozdemir N, Hillerdal G, Uçgun I, Metintas S, Baykul C, Elbek O, Mutlu S, Kolsuz M. Environmental asbestos exposure and malignant pleural mesothelioma. Respir Med 1999; 349-55.
8. 8. Albelda SM, Sterman DH, Litzky LA. Malignant mesothelioma and other primary pleural tumors. In: Fishman AP,Elias JA, eds. Fishman’s Pulmonary Diseases and Disorders. 3rd ed. Philadelphia: McGraw-Hill, 1998; 1453-1466.

9. 9. Tanrikulu AC, Senyigit A, Dagli CE, Babayigit C, Abakay A. Environmental malignant pleural mesothelioma in Southeast Turkey. Saudi Med J 2006; 27(10): 1605-7.
10. 10. Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax. 1976; 31(1): 15-24.
11. 11. Walz R, Koch HK. Malignant pleural mesothelioma: some aspects of epidemiology, diferential diagnosis and prognosis. Path Res Pract 1990; 186: 124-34.
12. 12. Chapman A, Mulrennan S, Ladd B, Muers MF. Population based epidemiology and prognosis of mesothelioma in Leeds, UK. Thorax 2008 63: 435-9.
13. 13. Senyi¤it A, Bayram H, Babayi¤it C, Topçu F, Nazaro¤lu H, Bilici A, Leblebici IH. Malignant pleural mesothelioma caused by environmental exposure to asbestos in the Southeast of Turkey: CT findings in 117 patients. Respiration 2000; 67(6): 615-22.
14. 14. Senyi¤it A, Babayi¤it C, Gökirmak M, Topçu F, Asan E, Coflkunsel M, Iflik R, Ertem M. Incidence of malignant pleural mesothelioma due to environmental asbestos fiber exposure in the southeast of Turkey. Respiration. 2000; 67(6): 610-4.
15. 15. Metintas M, Metintas S, Ucgun I, Gibbs AR, Harmanci E, Alatas F, Erginel S, Tel N, Pasaoglu O. Prognostic factors in diffuse malignant pleural mesothelioma: pretreatment clinical and laboratory characteristics. Resp Medicine 2001: 95: 829-35.
16. 16. Metintas S, Metintas M, Ucgun I, Oner U. Malignant mesothelioma due to environmental exposure to asbestos: follow-up of a Turkish cohort living in a rural area. Chest 2002; 122: 2224-9.
17. 17. Smith DD. Women and mesothelioma. Chest 2002; 122: 1885-6.
18. 18. De Klerk N. Environmental mesothelioma. In: JaurandM-C, Bignon J, eds. The Mesothelial Cell and Mesothelioma.New York, NY: Marcel Dekker, 1994; 19-35.
19. 19. Weill H, Hughes JM, Churg AM. Changing trends in US mesothelioma incidence. Occup Environ Med 2004; 61: 438-41.
20. 20. Marinaccio A, Binazzi A, Marzio DD, Scarselli A, Verardo M, Mirabelli D, Gennaro V, Mensi C, Riboldi L, Merler E, Zotti RD, Romanelli A, Chellini E, Silvestri S, Pascucci C, Romeo E, Menegozzo S, Musti M, Cavone D, Cauzillo G, Tumino R, Nicita C, Melis M, Iavicoli S; ReNaM Working Group. Pleural malignant mesothelioma epidemic: Incidence, modalities of asbestos exposure and occupations involved from the Italian National Register. Int J Cancer 2012; 130(9): 2146-54.
21. 21. Shao HJ, Ma JT, Yang XE, Xu LP, Yang CL. Diagnostic and therapeutic analyses for peritoneal malignant mesothelioma: a report of 26 women. Zhonghua Yi Xue Za Zhi 2011; 91(33): 2336-9.
22. 22. Alpar S, Uçar Z, Guven SF, Ayd›n Ö, Örsel O, A¤açk›ran Y, Kurt B. Malign Mezotelyomal› Kad›n Olgular›n Retrospektif De¤erlendirilmesi. Solunum Hastal›klar› 2007; 18: 108-113.
23. 23. Ribak J, Lilis R, Suzuki Y, Penner L, Selikoff IJ. Malignant mesotheliomain a cohort of asbestos insulation workers: Clinical presentation, diagnosis and causes of death. Br J Ind Med 1988; 45: 182-7.
24. 24. Öztürk E, Sayg› A, Saraç S ve ark. Malign plevral mezotelyoma: 92 vakan›n irdelenmesi. Solunum 2004; 6: 67-73